Free Shipping on purchases over €100

Mepilex Border Heel Apósito 22X23 cm, 3 unidades
Mepilex Border Heel Apósito 22X23 cm, 3 unidades
Mepilex Border Heel Apósito 22X23 cm, 3 unidades

Mepilex Border Heel Dressing 22X23 cm, 3 units

Mepilex Border Heel is a dressing designed to treat and prevent heel ulcers. Its absorbent foam structure and its ability to reduce friction and pressure make it an effective choice for the care of these wounds.

SKU: ME7333350985509
-21%
Promo FD
30.40
€38.55
€10.13
/1ud

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

When to use Mepilex Border Heel Treatment Mepilex® Border Heel has been specifically designed to fit the heel. The five-layer absorbent foam structure manages exudate and the wound environment. Mepilex Border is also designed for a wide variety of exuding wounds such as pressure ulcers, diabetic foot ulcers, traumatic wounds (e.g. lacerations) and surgical wounds. Pressure ulcer prevention Mepilex Border Heel has been shown to prevent pressure ulcers 3. You can apply the dressings prophylactically on all patients at risk. Scientific studies have shown that Mepilex Border Heel has an effect on extrinsic factors that contribute to the development of pressure ulcers by minimising and redistributing the extrinsic factors that contribute to the development of pressure ulcers.Scientific studies have shown that Mepilex Border Heel has an effect on extrinsic factors that contribute to pressure ulcers by minimising and redistributing friction and pressure, reducing friction and maintaining an optimal microclimate. Note: The use of dressings as a prophylactic treatment does not replace the need for a comprehensive pressure ulcer prevention protocol.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.